Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 88,173,144
  • Shares Outstanding, K 1,293,620
  • Annual Sales, $ 26,107 M
  • Annual Income, $ 4,628 M
  • 36-Month Beta 1.06
  • Price/Sales 4.04
  • Price/Cash Flow 7.08
  • Price/Book 3.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.63
  • Number of Estimates 8
  • High Estimate 2.04
  • Low Estimate 1.35
  • Prior Year 1.60
  • Growth Rate Est. (year over year) +1.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.32 +13.21%
on 12/26/18
69.15 -1.24%
on 01/08/19
+2.72 (+4.15%)
since 12/14/18
3-Month
60.32 +13.21%
on 12/26/18
76.29 -10.49%
on 10/17/18
-8.02 (-10.51%)
since 10/16/18
52-Week
60.32 +13.21%
on 12/26/18
89.54 -23.73%
on 01/29/18
-11.96 (-14.90%)
since 01/16/18

Most Recent Stories

More News
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know

Gilead Sciences (GILD) closed at $68.52 in the latest trading session, marking a +1.89% move from the prior day.

GILD : 67.71 (-1.18%)
First Annual Transgender March on Washington, D.C. to be held during Weekend of Solidarity and Celebration March 31-April 1, 2019

Members of the transgender and gender non-conforming communities will take a major stand against hate and discrimination when they rally in the nation's capital for the first ever National Trans Visibility...

GILD : 67.71 (-1.18%)
NASH Space in Focus in 2019 as Firms Look to Diversify

NASH is a highly lucrative market with blockbuster potential. Hence, we take a look at some of the companies in this space.

VKTX : 8.45 (-0.82%)
MRK : 74.95 (+0.60%)
NVS : 88.03 (+0.18%)
GILD : 67.71 (-1.18%)
RHHBY : 32.4900 (unch)
ICPT : 111.88 (-0.17%)
PFE : 42.44 (-0.68%)
Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus

It was a busy week for the biotech sector with most companies gaining on M&A activity. The annual J.P. Morgan Healthcare conference were also a key area of focus.

CELG : 87.79 (-0.50%)
ALNY : 81.74 (+1.60%)
LOXO : 233.25 (-0.18%)
SAGE : 134.72 (+2.11%)
GILD : 67.71 (-1.18%)
REGN : 405.81 (+0.20%)
BIIB : 333.10 (-1.32%)
Japan's Ministry of Health, Labour and Welfare Approves Gilead's Epclusa(R) (Sofosbuvir/Velpatasvir)

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Epclusa(R) (sofosbuvir 400mg/velpatasvir 100mg), a once-daily...

GILD : 67.71 (-1.18%)
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know

Gilead Sciences (GILD) closed at $68.56 in the latest trading session, marking a +0.45% move from the prior day.

GILD : 67.71 (-1.18%)
Gilead (GILD) Collaborates With Yuhan for NASH Candidates

Gilead (GILD) collaborates with Korean company Yuhan for the development of NASH treatments.

MRK : 74.95 (+0.60%)
ABBV : 86.13 (+0.74%)
GILD : 67.71 (-1.18%)
ICPT : 111.88 (-0.17%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.29 (+0.65%)
IBB : 108.87 (-0.34%)
QGEN : 36.55 (+0.77%)
GILD : 67.71 (-1.18%)
REGN : 405.81 (+0.20%)
XBI : 82.24 (+0.05%)
Biotech Rally Ahead of the Market

HENDERSON, NV / ACCESSWIRE / January 2, 2019 / Biotech hit its bear market phase weeks before the market as a whole did. Some analysts think this means the turnaround will come sooner. Here's a few biotech...

VTVT : 2.56 (+2.81%)
ENDV : 0.0300 (+3.45%)
GILD : 67.71 (-1.18%)
PTLA : 25.77 (+3.33%)
Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that members of the executive management team will participate in a fireside chat at the 37th Annual J.P. Morgan Healthcare Conference...

JPM : 102.62 (+0.92%)
GILD : 67.71 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade GILD with:

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 69.77
1st Resistance Point 69.14
Last Price 67.71
1st Support Level 67.46
2nd Support Level 66.41

See More

52-Week High 89.54
Fibonacci 61.8% 78.38
Fibonacci 50% 74.93
Fibonacci 38.2% 71.48
Last Price 67.71
52-Week Low 60.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar